North America holds a substantial share of the Generic Oncology Drugs Market, driven by the high prevalence of cancer, increasing healthcare expenditures, and strong emphasis on cost-effective treatment solutions. The region is witnessing growing adoption of generic oncology drugs as healthcare providers, insurers, and government agencies seek to reduce the financial burden associated with...